Prioritising Drug Targets in non-canonical pathways from multi-omic data

There exists a large and rapidly growing body of publicly available datasets from studies that monitor cellular response to perturbation using methods such as bulk and single cell transcriptomics, LS-MS/MS proteomics and phosphoproteomics, metabolomics and epigenetics. While individual studies are useful in their own right, large scale…